Loading clinical trials...
Loading clinical trials...
Randomised, Double-Blind, Placebo-Controlled, Crossover Study Investigating the Role of Potassium Channels in Working Memory Impairments of Chronic Cocaine Users
Conditions
Interventions
4-aminopyridine (4-AP)
Placebo
Locations
1
Switzerland
University Hospital of Psychiatry Zurich
Zurich, Canton of Zurich, Switzerland
Start Date
April 1, 2026
Primary Completion Date
August 1, 2027
Completion Date
August 1, 2027
Last Updated
April 20, 2026
NCT05896189
NCT07071779
NCT01071044
NCT07069530
NCT06212726
NCT04490330
Lead Sponsor
Boris Quednow
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions